Y-mAbs Therapeutics, Inc. (YMAB)
Sep 15, 2025 - YMAB was delisted (reason: acquired by SERB Pharmaceuticals)
8.61
+0.02 (0.23%)
Inactive · Last trade price on Sep 15, 2025
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics is not actively traded anymore. When Y-mAbs Therapeutics last traded, it had a market cap or net worth of $391.22 million.
Market Cap
391.22M
Enterprise Value
332.06M
1-Year Change
-42.96%
Ranking
Category
Stock Price
$8.61
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $391.22M, a decrease of -50.90%. That is a compound annual growth rate of -9.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 391.22M | 11.56% |
Dec 31, 2024 | 350.70M | 17.88% |
Dec 29, 2023 | 297.50M | 39.61% |
Dec 30, 2022 | 213.10M | -69.88% |
Dec 31, 2021 | 707.47M | -64.73% |
Dec 31, 2020 | 2.01B | 61.56% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition